Long-Term Safety Evaluation of Continuous Intraocular Delivery of Aflibercept by the Intravitreal Gene Therapy Candidate ADVM-022 in Nonhuman Primates - Concepedia

Concepedia

Publication | Open Access

Long-Term Safety Evaluation of Continuous Intraocular Delivery of Aflibercept by the Intravitreal Gene Therapy Candidate ADVM-022 in Nonhuman Primates

DOI Full Paper Access

35

Citations

31

References

2021

Year

Szilárd Kiss, Kristina Oresic Bender, Ruslan N. Grishanin, Kelly Hanna, Julio Nieves, Pallavi Sharma, Aivan Nguyen, Romeo J. Rosario, Judith S. Greengard, Claire M. Gelfman,

Translational Vision Science & Technology

Abstract

Together with the results from previous ADVM-022 preclinical studies, these data support the evaluation of this gene therapy candidate in clinical trials as a potential durable treatment for various VEGF-mediated ophthalmic disorders.

References

	Year	Citations

Page 1